<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04954898</url>
  </required_header>
  <id_info>
    <org_study_id>DIOL-301-CZMT</org_study_id>
    <nct_id>NCT04954898</nct_id>
  </id_info>
  <brief_title>Post-market Evaluation of Clinical Outcomes in China for the TECNIS Model ZMT</brief_title>
  <official_title>Post-market Evaluation of Clinical Outcomes in China for the TECNIS® Multifocal Toric 1-Piece Intraocular Lens Model Series ZMT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Surgical Vision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Surgical Vision, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multicenter, single-arm, open-label clinical study of the commercially&#xD;
      available TECNIS Multifocal Toric 1-Piece IOL. The study will enroll up to 120 subjects from&#xD;
      up to 5 sites in China. The subjects will be followed for 12-months postoperatively.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 11, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of eyes that are measured at the 1-day postoperative visit to demonstrate ≤10º change from The intended IOL axis at the end of surgery.</measure>
    <time_frame>1 day postoperative</time_frame>
    <description>The axis change is calculated as the absolute difference between intended IOL axis and the axis measured at follow-up visit(s).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Study Lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TECNIS Multifocal Toric 1-piece lens, Model ZMT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Study Lens: TECNIS Multifocal Toric 1-piece lens, Model ZMT</intervention_name>
    <description>Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with TECNIS Multifocal Toric 1-Piece IOL.</description>
    <arm_group_label>Study Lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female at least 22 years of age&#xD;
&#xD;
          2. Have a cataract in one or both eyes, with planned phacoemulsification with intraocular&#xD;
             lens implantation&#xD;
&#xD;
          3. Regular corneal astigmatism that is planned for correction with an intraocular lens in&#xD;
             the study eye(s)&#xD;
&#xD;
          4. Availability, willingness and sufficient cognitive awareness to understand the purpose&#xD;
             of the examination procedures and comply with postoperative visits that are required&#xD;
             by the study protocol&#xD;
&#xD;
          5. Voluntary participation indicated by the study informed consent form (ICF) signed by&#xD;
             the patient or legal guardian.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Concurrent participation or participation in any other clinical study within 30 days&#xD;
             prior to the preoperative visit&#xD;
&#xD;
          2. Ocular disease (other than cataract) that may significantly affect postoperative&#xD;
             vision, such as visually significant keratopathy, macular lesions, diabetic&#xD;
             retinopathy, chronic or severe uveitis, etc.&#xD;
&#xD;
          3. Planned monovision correction (one eye designated for near correction)&#xD;
&#xD;
          4. Severe or unstable systemic disease that may affect the heart, liver, kidney, lung,&#xD;
             endocrine (including thyroid insufficiency), blood, or psychoneurological dysfunction&#xD;
&#xD;
          5. Any other systemic or ocular disease that, in the opinion of the investigator, may&#xD;
             affect the patient's eligibility for the study.&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johnson &amp; Johnson Surgical Vision Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>Johnson &amp; Johnson Surgical Vision</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Contact</last_name>
    <phone>+1 904 9553543</phone>
    <email>AANDERS1@its.jnj.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eye Hospital, Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 29, 2021</study_first_submitted>
  <study_first_submitted_qc>June 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Devices Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA project site at http://yoda.yale.edu</ipd_description>
    <ipd_url>http://yoda.yale.edu</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

